Launch of the Versius surgical robotic system in France as CMR Surgical expands its global presence
·Clinique du Parc hospital, Saint-Étienne, is the first to use Versius in France – the largest market for surgical robotics in Europe and the third in the world
CAMBRIDGE, UK – SEPTEMBER 18, 2020. 00:01 (GMT). CMR Surgical today announced the launch of its Versius® surgical robotic system at Clinique du Parc Hospital in Saint-Étienne, France. France is the leading European robotics market and the third in the world. The arrival of Versius offers a versatile option that can support a much higher usage of robotic minimal access surgery (MAS), also known as keyhole surgery. Versius is used to conduct procedures such as hernia repair surgeries, prostatectomies, and hysterectomies. MAS is a leading standard of care and is associated with better patient outcomes and shorter hospital stays compared to open surgery – two factors that are increasingly important as healthcare services continue to grow. seek rigorous ways to minimize exposure to COVID-19.
By Vegard Nerseth, Comment from the CEO of CMR Surgical: “France is one of the largest markets for surgical robotics in the world and we are delighted to launch Versius in such an influential region. With Versius, we’ve created a unique system with the potential to radically transform surgery – making the best surgical care more accessible than ever. Over the past year, CMR has seen worldwide interest in Versius grow exponentially and today is another important step forward as we continue to bring this pioneering technology to surgeons and hospitals across the world. ‘Europe and beyond.
Versius brings next generation technology to MAS. It can be easily moved and used in virtually any operating room, meaning that a single Clinique du Parc system could be used to treat up to 300 cases each year. It also offers a way to make surgical robotics more available on a systematic basis, addressing inequalities in access to surgical robotics technology. Across France, more than 1,500 hospitals currently perform SAMs, but only 6% of medium-sized public hospitals have a robotic surgery department.is Versius aims to offer an innovative solution to this challenge, making MAS much more accessible.
Karine Giroudon, Division Director at C2S and Director of the Clinique du Parc, welcomes the acquisition of Versius: “The arrival of Versius is a remarkable opportunity for Clinique du Parc, the first hospital in France to benefit from this exceptional technology. The versatility of Versius and the fact that it is easily transportable means that we have total flexibility. Unlike all of the above, Versius can be used multiple times a day, in different theaters and by teams working in multiple disciplines such as gastroenterology, urology, and gynecology. Our surgical teams are leading the way in the use of this surgical tool, allowing us to bring the benefits of MAS to more patients than ever before.
– ENDS –
If you would like to know more, please contact CMR Surgical at:
Sarah Ghabina / Ashley Davis-Marin
Global Communications Manager / Senior Communications Executive, CMR Surgical
T +44 (0) 1223 755801
E [email protected]
Tim Cockroft, akt Health Communications
T +44 (0) 7957 325 583
E [email protected]
Notes to Editors:
About Versius at Clinique du Parc
Versius aims to ensure that surgeons and hospitals are able to provide patients with the highest quality surgical care. At Clinique du Parc, it has been used to perform a wide range of SAM procedures, such as hernia repair surgeries, prostatectomies and hysterectomies. These procedures are often complex and can take several hours. Using a robotic MAS in these cases can dramatically reduce the physical pressure on the surgeon, reduce a patient’s recovery time from weeks to days, and reduce the risk of surgical site infections – a costly problem. up to € to health services in Europe. 19 billion per year.ii
The Clinique du Parc is part of the C2S group, leader in healthcare in the Auvergne Rhône-Alpes and Bourgogne Franche-Comté regions. The Clinique du Parc treats more than 150,000 patients each year and performs around 15,000 surgeries. While robotic MAS historically has been prohibitively expensive for many hospitals (especially smaller centers), CMR Surgical has designed Versius to be versatile and cost effective, available through financial models that provide budget certainty and support the regular use of the system.
The Versius® Surgical robotic system
Versius® resets expectations for robotic surgery. Versius fits into virtually any operating room setup and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access (MAS) surgery. Versius’ portable and modular design allows the surgeon to use only the number of arms needed for a given procedure.
Biomimicating the human arm, Versius offers surgeons the choice of optimized port placement as well as the dexterity and precision of small full wrist instruments. With 3D HD vision, easy-to-adopt instrument control and a choice of ergonomic working positions, the open surgeon’s console has the potential to reduce stress and fatigue and allows clear communication with the surgical team. With laparoscopy in mind and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value robotic MAS brings.
About CMR Surgical Limited
CMR Surgical (CMR) is a global medical device company dedicated to transforming surgery with Versius®, a new generation surgical robot.
Based in Cambridge, UK, CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool for making minimum access robotic surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is a limited liability company backed by a base of international shareholders.
isDr Jean-Claude COUFFINHAL. Report on the professional, HR, organization and population impact of the progressive territorial deployment of surgical robots in CHUs in the Ile-de-France region and outside CHUs. Ile de France regional health agency. June 2019.
iiDavid J Leaper et al., Surgical site infection – a European perspective on the incidence of economic burden. International Journal of Wounds. December 2004.